Next Article in Journal
Electrochemical Recognition of Metalloproteins by Bromide-modified Silver Electrode - A New Method
Previous Article in Journal
Solubilization of Single-walled Carbon Nanotubes with Single- stranded DNA Generated from Asymmetric PCR
Article Menu

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2007, 8(7), 714-722;

3D-QSAR Study of Potent Inhibitors of Phosphodiesterase-4 Using a CoMFA Approach

College of Pharmacy, Jinan University, Guangzhou, P.R. of China
Author to whom correspondence should be addressed.
Received: 5 June 2007 / Revised: 13 July 2007 / Accepted: 19 July 2007 / Published: 24 July 2007
(This article belongs to the Section Physical Chemistry, Theoretical and Computational Chemistry)
Full-Text   |   PDF [194 KB, uploaded 19 June 2014]


Phosphodiesterase-4 (PDE4) plays an important role in treatment of asthma andchronic obstructive pulmonary disease. Thirty-one analogs displaying variable inhibition ofPDE4 were selected to develop models for establishing three-dimensional quantitativestructure-activity relationships (3D-QSAR). Comparative molecular field analysis(CoMFA) was conducted on the group of analogs to determine the structural requirementsfor potency in inhibiting PDE4. The resulting model exhibited good q2 and r2 values up to0.741 and 0.954 for CoMFA. The contributions from the steric and electrostatic fields were0.915 and 0.085 respectively. The 3D-QSAR model should be very useful for design ofnovel PDE 4 inhibitors. View Full-Text
Keywords: QSAR; CoMFA; Phosphodiesterase-4 QSAR; CoMFA; Phosphodiesterase-4
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Yang, Z.; Sun, P. 3D-QSAR Study of Potent Inhibitors of Phosphodiesterase-4 Using a CoMFA Approach. Int. J. Mol. Sci. 2007, 8, 714-722.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top